½ÃÀ庸°í¼­
»óǰÄÚµå
1403529

¼¼°è È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå ¿¹Ãø(-2030³â) : ½Ã¼³ À¯Çüº°, óġ À¯Çüº°, È­»ó ÁßÁõµµº°, ¼­ºñ½º À¯Çüº°, Áö¿ªº° ºÐ¼®

Burn Care Centers Market Forecasts to 2030 - Global Analysis By Facility Type, Procedure Type, Burn Severity, Service Type and by Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀåÀº 2023³â¿¡ 246¾ï 4,000¸¸ ´Þ·¯¸¦ Â÷Áö?°í ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 6.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 375¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

È­»ó Ä¡·á ¼¾ÅÍ´Â È­»ó ȯÀÚ¿¡°Ô Á¾ÇÕÀûÀÎ °ü¸® ¹× ÀçȰÀ» Á¦°øÇÏ´Â µ¥ Àü³äÇÏ´Â Àü¹® ÀÇ·á ½Ã¼³ÀÔ´Ï´Ù. ÀÌ ½Ã¼³Àº È­»óÀ» ÀÔÀº ÈÄ Àüü Ä¡·á °úÁ¤ Áß ¹× ÈÄ¼Ó Àü¹® Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ È­»ó ¿Ü°ú ÀÇ»ç, °£È£»ç ¹× Ä¡·á»ç´Â È­»óÀ¸·Î ÀÎÇÑ Æ¯º°ÇÑ ¾î·Á¿òÀ» ÇØ°áÇϱâ À§ÇØ Çù·ÂÇÏ´Â °í±Þ ÀÚ°ÝÀ» °®Ãá ÀÇ·á Àü¹®°¡ Áß ÇÑ ¸íÀÔ´Ï´Ù. È­»ó Ä¡·á ¼¾ÅÍÀº ÅëÁõÀ» Á¶ÀýÇÏ°í °¨¿°À» ¿¹¹æÇÏ°í °¡´ÉÇÑ ÃÖ»óÀÇ Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇØ Çö´ë ±â¼ú°ú Ä¡·á Á¢±Ù¹ýÀ» »ç¿ëÇÕ´Ï´Ù.

CDC¿¡ µû¸£¸é È­»ó°ú »ç°í´Â °¡Á¤¿¡¼­ »ç»óÀÚÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¹Ì±¹ È­»ó Çùȸ¿¡ µû¸£¸é Ä¡·á ¼¾ÅÍ·Î À̼۵Ǵ ¸ðµç »ç·ÊÀÇ 40% ÀÌ»óÀÌ È­»óÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

Áõ°¡ÇÏ´Â È­»ó

È­»ó Ä¡·á ¼¾ÅÍ´Â °¡Á¤ ³» Àç³­, »ê¾÷ »ç°í, ÀÚ¿¬ ÀçÇØ·Î ÀÎÇÑ È­»ó Áõ°¡¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇØ¾ßÇÕ´Ï´Ù. µµ½ÃÈ­¿Í Àα¸ Áõ°¡°¡ °è¼ÓµÇ´Â ÇÑ, Àü¹®ÀûÀÎ Äɾî¿Í ÀçȰ ÇÁ·Î±×·¥ÀÇ Çʿ伺Àº ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ È¯ÀÚÀÇ º¹ÀâÇÑ ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇØ È­»ó Ä¡·á ¼¾ÅÍ´Â Àû±ØÀûÀÎ ¿¹¹æ Á¶Ä¡¸¦ ÃëÇÏ°í ¹ß»ýÇÑ ¹®Á¦¿¡ ½Å¼ÓÇÏ°Ô ´ëóÇÔÀ¸·Î½á »óÇØ ÆÐÅÏÀÇ º¯È­¿¡ ÀûÀÀÇØ¾ßÇÕ´Ï´Ù ÀÔ´Ï´Ù.

°í¾×ÀÇ ÀÇ·áºñ

È­»ó Ä¡·á¿¡´Â Àå±â°£ÀÇ ÀçȰ, ¼ö¼ú ¹× ÀÀ±Þ Ä¡·á°¡ ÇÊ¿äÇÏ¸ç ¸Å¿ì ºñ½Ñ ÀÇ·áºñ°¡ ºÎ°úµË´Ï´Ù. ȯÀÚÃþ¿¡ µû¶ó¼­´Â °í¾×ÀÇ Ä¡·áºñ¸¦ ÁöºÒÇÏ±â ¾î·Æ°í, Ä¡·á°¡ Áö¿¬µÇ°Å³ª ÃæºÐÈ÷ Á¦°øµÇÁö ¾ÊÀ» °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁöºÒÀÚ, ÀÇ·á Á¦°ø¾÷ü, ÀÇ·á Á¤Ã¥ ÀÔ¾ÈÀÚÀÇ ÇùÁ¶ÀûÀÎ ³ë·ÂÀÌ ÄɾîÀÇ ÁúÀ» Èñ»ýÇÏÁö ¾Ê°í °æÁ¦Àû ºÎ´ãÀ» º¸ÀåÇÏ´Â Áö¼Ó °¡´ÉÇÑ ÀÚ±Ý Á¶´Þ ¸ðµ¨À» ±¸ÃàÇÔÀ¸·Î½á È­»ó Ä¡·áÀÇ °æÁ¦Àû ºÎ´ãÀ» ´Ù·ç´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù.

¿ø°Ý ¸ð´ÏÅ͸µ ¹× ¿ø°Ý ÀÇ·á °³¹ß

È­»ó Ä¡·á ¼¾ÅÍ´Â ²÷ÀÓ¾ø´Â ¿ø°Ý ÀÇ·á Áøº¸ ´öºÐ¿¡ ¼­ºñ½º¸¦ È®ÀåÇϰí ÁøÂû, ÈÄ¼Ó Á¶Ä¡ ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â Å« ±âȸ¸¦ ¾ò°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á±â¼úÀ» µµÀÔÇÔÀ¸·Î½á ÃæºÐÇÑ ¼­ºñ½º¸¦ ¹ÞÀ» ¼ö ¾ø´Â Áö¿ªÀ̳ª ¿ø°ÝÁöÀÇ È¯ÀÚ´Â º¸´Ù ÁÁÀº Äɾ ¹ÞÀ» ¼ö ÀÖ°í, Áö¼ÓÀûÀÎ Äɾ ¿ëÀÌÇØÁö±â ¶§¹®¿¡ ´ë¸é¿¡¼­ÀÇ ÁøÂûÀÇ È½¼ö°¡ ÁÙ¾îµì´Ï´Ù. °Ô´Ù°¡ ÀÌ Àü·«Àº º¸´Ù ¸é¹ÐÇÏ°í °³º°È­µÈ Äɾî Ç÷£À¸·Î À̾îÁ® Åð¿ø ÈÄ ¸ð´ÏÅ͸µÀ» ´Ã¸®°í ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

°ø±Þ¸Á È¥¶õ°ú ÀǾàǰ ºÎÁ·

ÀǾàǰ °ø±Þ¸ÁÀÇ ÀǾàǰ ºÎÁ·°ú È¥¶õÀº È­»ó Ä¡·á ¼¾ÅÍ¿¡ À§ÇùÀÌ µË´Ï´Ù. ÇʼöÀûÀÎ ¾à¹°, ºØ´ë ¹× ÀÇ·á¿ëǰÀÇ ºÎÁ·Àº È­»ó ȯÀÚ¿¡°Ô Á¦°øµÇ´Â Ä¡·áÀÇ ÁúÀ» ÀúÇϽÃų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡´ÉÇÑ È¥¶õÀÇ ¿µÇâÀ» ÁÙÀ̱â À§ÇÑ Áß¿äÇÑ Àü¼úÀº °ø±Þ¾÷ü¿Í Àü·«Àû Á¦ÈÞ¸¦ ¸Î°í, ´Ù¾çÇÑ °ø±Þ¸ÁÀ» À¯ÁöÇϰí, Àç°í¸¦ ÁÖ½ÃÇÏ°í °ü¸®ÇÏ´Â °ÍÀÔ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀåÀº COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â ±âȸ¿Í µµÀü ¸ðµÎ¸¦ °¡Á®¿É´Ï´Ù. COVID-19 Áõ·Ê Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ, ÇコÄɾî ÀηÂ, ÀÎÇÁ¶ó, ÀÚ¿øÀÇ ÀçºÐ¹è°¡ ÇàÇØÁ®, È­»ó Ä¡·á ¼­ºñ½º´Â Ç̹ÚÇϰí ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ Ä¡·á, ¼±ÅÃÀû Ä¡·á ¹× ÀçȰ¿¡ Áö¿¬ÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °¨¿° ´ëÃ¥ÀÌ Á߽õǾî ÀÇ·á ¹°ÀÚÀÇ ·çÆ®°¡ º¯°æµÇ¾ú±â ¶§¹®¿¡ ÃÖ°í ¼öÁØÀÇ È­»ó Ä¡·á¸¦ À¯ÁöÇÏ´Â °ÍÀÌ ¾î·Á¿öÁ³½À´Ï´Ù. ÇÑÆí, À¯ÇàÀº µðÁöÅÐ ÀÇ·á ¹× ¿ø°Ý ÀÇ·áÀÇ º¸±ÞÀ» ÃËÁøÇϰí È­»ó Ä¡·á¿¡¼­ ¿ø°Ý ÈļÓ, ¸ð´ÏÅ͸µ ¹× ÁøÂû ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

¿¹Ãø±â°£ µ¿¾È »óó°ü¸® ºÐ¾ß°¡ ÃÖ´ëÈ­µÉ Àü¸Á

»óó °ü¸®°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È­»ó, ºÎ»ó, ¼ö¼ú µî ´Ù¾çÇÑ À¯ÇüÀÇ »óó¸¦ Ä¡·áÇÏ´Â Á¾ÇÕÀûÀÎ Á¢±Ù¹ýÀº »óó °ü¸®·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. Ä¡À¯ °úÁ¤À» ±Ø´ëÈ­Çϱâ À§ÇØ ÃÖ÷´Ü »óó Äɾî Á¦Ç° ¹× ±â¼úÀ» »ç¿ëÇÑ »óó Æò°¡, ¼¼Ã´, ÆÄ±«ÀÚ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, »óó °ü¸® ½ÃÀåÀº ȯÀÚ Áß½ÉÀÇ Äɾî¿Í »óó ÄÉ¾î ±â¼úÀÇ °³¹ß¿¡ ÁßÁ¡À» µÎ°Ô µÇ¾ú±â ¶§¹®¿¡ Áö±Ýµµ ¸¹Àº ±â¼ú Çõ½ÅÀÌ ÀϾ°í ÀÖ½À´Ï´Ù. ¸¸¼º »óó Áõ°¡, Àα¸ °í·ÉÈ­, ´ç´¢º´ µî Áúº´ÀÇ À¯º´·ü Áõ°¡°¡ÀÌ ½ÃÀåÀÌ ÁÖ¸ñ¹Þ´Â ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)ÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº ¿Ü·¡ ȯÀÚ ºÎ¹®ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿Ü·¡ ȯÀÚ ºÎ¹®Àº ½ÃÀå¿¡¼­ °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¿Ü·¡ ȯÀÚ¿ë ¼­ºñ½ºÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ´Â ¹è°æÀ¸·Î´Â Àú·ÅÇÑ °¡°Ý, »ç¿ëÀÇ ¿ëÀ̼º, °¡Ä¡¿¡ ±Ù°ÅÇÑ ÄÉ¾î ¸ðµ¨ÀÇ Ã¤¿ë µîÀÌ ÀÖ½À´Ï´Ù. °æ°ú °üÂû, ¼Ò¼ö¼ú, Áø´Ü óġ µî Æø³ÐÀº ÀÇ·á ¼­ºñ½º°¡ ¿Ü·¡·Î Á¦°øµÇ¾î ¼÷¹ÚÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê½À´Ï´Ù. ¶ÇÇÑ, ¿ø°ÝÀÇ·á, Àúħ½À ¼ö¼ú, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µî ÀÇ·á¿¡¼­ÀÇ ±â¼ú °³¹ßÀÌ ¿Ü·¡ ¼­ºñ½º ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀåÀº ÷´Ü ÀÇ·á ±â¼ú, Á¤ºñµÈ °Ç°­ °ü¸® ÀÎÇÁ¶ó, È­»óÀÇ ¹ß»ý·üÀÌ ³ô±â ¶§¹®¿¡ ºÏ¹Ì¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ÀÌ Áö¿ªÀÇ ÁöÀ§¸¦ ´õ¿í ³ôÀ̰í ÀÖ´Â °ÍÀº µ¿ ½ÃÀåÀÇ ´ë±â¾÷, Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·Â, ÇコÄɾîÀÇ Áú°ú ±âÁØ¿¡ ´ëÇÑ °­ÇÑ °íÁýÀÔ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀåÀº ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀº È­»ó Áõ°¡, °Ç°­ °ü¸® ÀÎÇÁ¶ó °³¼±, È­»ó Ä¡·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, È­»ó Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. Áß±¹°ú Àεµ µî ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ ÀÇ·á ½Ã¼³°ú ±â¼úÀÇ ÇöÀúÇÑ ¹ßÀüÀ¸·Î È­»ó Ä¡·á »ê¾÷ÀÌ ¼ºÀåÇØ ¿Ô½À´Ï´Ù. ¶ÇÇÑ Áö¿ª °Ç°­ °ü¸®ÀÇ Áú°ú Á¢±Ù¼º¿¡ ´ëÇÑ ³ë·Â°ú Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ °á°ú·Î Àü¹®ÀûÀÎ È­»ó Ä¡·á ¼­ºñ½ºÀÇ Çʿ伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù.

»ç¿ëÀÚ Á¤ÀÇ ¹«·á Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå : ½Ã¼³ À¯Çüº°

  • º´¿ø ³»
  • µ¶¸³Çü
  • ±âŸ ½Ã¼³ À¯Çü

Á¦6Àå ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå : óġ À¯Çüº°

  • »óó¸é ÀýÁ¦¼ú
  • ÇǺΠÀ̽Ä
  • »óó °ü¸®
  • È£Èí»ð°ü ¹× ȯ±â
  • ÅëÁõ °ü¸®
  • ¼öÇ÷
  • °¨¿° ÅëÁ¦
  • ±âŸ ¼ö¼Ó À¯Çü

Á¦7Àå ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå : È­»ó ÁßÁõµµº°

  • °æµµ È­»ó
  • ºÎºÐ È­»ó
  • ÀüÃþ È­»ó

Á¦8Àå ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå : ¼­ºñ½º À¯Çüº°

  • ÀÔ¿øÈ¯ÀÚ
  • ¿Ü·¡
  • ÀçȰ
  • ±âŸ ¼­ºñ½º À¯Çü

Á¦9Àå ¼¼°èÀÇ È­»ó Ä¡·á ¼¾ÅÍ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Medtronic Plc.
  • Johnson & Johnson
  • Molnlycke Health Care
  • ConvaTec Group PLC
  • Molnlycke Health Care AB
  • Derma Sciences
  • Coloplast A/S
  • Acelity LP Inc.
  • Shire plc.
  • 3M Company
  • Smith & Nephew plc.
  • Integra LifeSciences Corporation
JHS 24.01.23

According to Stratistics MRC, the Global Burn Care Centers Market is accounted for $24.64 billion in 2023 and is expected to reach $37.54 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Burn care centers are specialized medical establishments devoted to providing patients with burn injuries with all-encompassing care and rehabilitation. These facilities are vital to the provision of specialized care, both during and after the whole healing process following a burn occurrence. Moreover, burn surgeons, nurses, and therapists are among the highly qualified medical professionals who work together to address the special difficulties brought on by burn injuries. Modern technology and therapeutic approaches are used in burn care facilities to control pain, stop infections, and encourage the best possible healing.

According to CDC, burn injuries or accidents are one of the leading causes of home casualties. American Burn Association states that over 40% of all cases coming to treatment facilities are due to fire and flame burns.

Market Dynamics:

Driver:

Increasing number of burn injuries

Burn care facilities must act quickly in response to the rising number of burn injuries caused by domestic mishaps, industrial accidents, and natural disasters. The need for specialized care and rehabilitation programs is only going to increase as long as urbanization and population growth continue. Additionally, in order to meet the complex needs of a diverse patient population, burn care centers must adjust to changing patterns of injuries by putting proactive preventative measures in place and acting quickly to address any issues that arise.

Restraint:

Expensive medical care

Burn care can be very expensive, requiring long-term rehabilitation, surgeries, and emergency treatment. Certain patient populations may find it difficult to afford expensive treatment, which could cause care to be delayed or provided insufficiently. Furthermore, a coordinated effort by payers, providers, and healthcare policymakers is needed to address the financial burden of burn treatment by creating sustainable financing models that guarantee affordability without sacrificing care quality.

Opportunity:

Developments in remote monitoring and telemedicine

Burn care centers have a great chance to expand their services and offer consultations, follow-ups, and remote monitoring thanks to the continuous advancements in telemedicine. By incorporating telehealth technologies, patients in underserved or remote areas can receive better care and see fewer in-person visits as continuous care is made easier. Moreover, this strategy can lead to more thorough and individualized care plans, increase post-discharge monitoring, and increase patient compliance.

Threat:

Disruptions to the supply chain and drug shortages

Drug shortages and disruptions in the pharmaceutical supply chain pose a threat to burn care facilities. Lack of essential drugs, bandages, and medical supplies can lower the quality of care given to burn patients. Additionally, important tactics to lessen the effects of possible disruptions include forming strategic alliances with suppliers, keeping diverse supply chains, and keeping a close eye on and controlling inventory.

COVID-19 Impact:

The market for burn care facilities has been significantly impacted by the COVID-19 pandemic, which has brought with it both opportunities and challenges. Burn care services are under pressure due to the redirection of healthcare personnel, infrastructure, and resources to handle the increase in COVID-19 cases. This could cause delays in treatment, elective procedures, and rehabilitation efforts. Furthermore, maintaining the highest standards of burn care has become more difficult due to the increased emphasis on infection control and the rerouting of medical supplies. On the other hand, the pandemic has also expedited the uptake of digital health and telemedicine, providing chances for remote follow-ups, monitoring, and consultations in burn care.

The Wound Management segment is expected to be the largest during the forecast period

The wound management is projected to have the largest share. A comprehensive approach to treating different kinds of wounds, such as those from burns, injuries, or surgical procedures, is known as wound management. In order to maximize the healing process, this section includes wound assessment, cleaning, and debridement using cutting-edge wound care products and techniques. Moreover, the wound management market is still seeing a lot of innovation because of the increased focus on patient-centric care and the developments in wound care technologies. Growing rates of chronic wounds, an aging population, and the rising prevalence of diseases like diabetes are some of the main causes of its notoriety.

The Outpatient segment is expected to have the highest CAGR during the forecast period

Over the course of the forecast period, the outpatient segment is growing at the highest CAGR in the market. The increasing popularity of outpatient services can be attributed to their affordability, ease of use, and the adoption of value-based care models. A broad range of medical services, such as follow-up consultations, minor surgeries, and diagnostic procedures, are provided in the outpatient setting and do not necessitate an overnight stay. Furthermore, technological developments in medicine, including telemedicine, minimally invasive procedures, and ambulatory surgical centers, are the main drivers of the growth in outpatient services.

Region with largest share:

The market for burn care facilities is anticipated to hold the largest share in the North American region, due to their advanced medical technologies, well-established healthcare infrastructure, and high rate of burn injuries. However, further bolstering the region's standing are the major players in the market, continuous R&D endeavors, and a strong focus on healthcare quality and standards.

Region with highest CAGR:

The burn care centers market is expected to grow at the highest CAGR in the Asia-Pacific region. The region's growth can be attributed to various factors, including a rise in burn injuries, improved healthcare infrastructure, increased investments in burn care, and growing awareness of burn care. The burn care industry has grown as a result of notable developments in medical facilities and technologies in emerging economies in the Asia-Pacific region, such as China and India. Additionally, the need for specialized burn care services has also increased as a result of regional healthcare quality and accessibility initiatives and government initiatives.

Key players in the market:

Some of the key players in Burn Care Centers market include Medtronic Plc., Johnson & Johnson, Molnlycke Health Care, ConvaTec Group PLC, Molnlycke Health Care AB, Derma Sciences, Coloplast A/S, Acelity L.P. Inc., Shire plc., 3M Company, Smith & Nephew plc. and Integra LifeSciences Corporation.

Key Developments:

In July 2023, Janssen, a Johnson & Johnson company, has entered into a global licensing agreement with Nanobiotix worth over $2.5bn to gain the global rights to a drug designed to enhance the efficacy of radiotherapy. Janssen will pay Nanobiotix $60m in upfront fees and funding for an exclusive worldwide licence to NBTXR3, with the France-based biotech eligible for success-based milestone payments of up to $1.8bn.

In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device - a tubeless, wearable and fully disposable insulin delivery device.

In April 2023, Medical products and technologies business Convatec Group has acquired an anti-infective nitric oxide technology platform. The platform of 30 Technology Ltd includes new product assets and research and development. In addition to applications in advanced wound care, Convatec will explore application of this technology platform across its business categories.

Facility Types Covered:

  • In-hospital
  • Standalone
  • Other Facility Types

Procedure Types Covered:

  • Wound Debridement
  • Skin Graft
  • Wound Management
  • Respiratory Intubation and Ventilation
  • Pain Management
  • Blood Transfusion
  • Infection Control
  • Other Procedure Types

Burn Severities Covered:

  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns

Service Types Covered:

  • Inpatient
  • Outpatient
  • Rehabilitation Centers
  • Other Service Types

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Burn Care Centers Market, By Facility Type

  • 5.1 Introduction
  • 5.2 In-hospital
  • 5.3 Standalone
  • 5.4 Other Facility Types

6 Global Burn Care Centers Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Wound Debridement
  • 6.3 Skin Graft
  • 6.4 Wound Management
  • 6.5 Respiratory Intubation and Ventilation
  • 6.6 Pain Management
  • 6.7 Blood Transfusion
  • 6.8 Infection Control
  • 6.9 Other Procedure Types

7 Global Burn Care Centers Market, By Burn Severity

  • 7.1 Introduction
  • 7.2 Minor Burns
  • 7.3 Partial Thickness Burns
  • 7.4 Full Thickness Burns

8 Global Burn Care Centers Market, By Service Type

  • 8.1 Introduction
  • 8.2 Inpatient
  • 8.3 Outpatient
  • 8.4 Rehabilitation
  • 8.5 Other Service Types

9 Global Burn Care Centers Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc.
  • 11.2 Johnson & Johnson
  • 11.3 Molnlycke Health Care
  • 11.4 ConvaTec Group PLC
  • 11.5 Molnlycke Health Care AB
  • 11.6 Derma Sciences
  • 11.7 Coloplast A/S
  • 11.8 Acelity L.P. Inc.
  • 11.9 Shire plc.
  • 11.10 3M Company
  • 11.11 Smith & Nephew plc.
  • 11.12 Integra LifeSciences Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦